View Financial HealthOngwe Minerals 配当と自社株買い配当金 基準チェック /06Ongwe Minerals配当金を支払った記録がありません。主要情報n/a配当利回り-2.7%バイバック利回り総株主利回り-2.7%将来の配当利回りn/a配当成長n/a次回配当支払日n/a配当落ち日n/a一株当たり配当金n/a配当性向n/a最近の配当と自社株買いの更新更新なしすべての更新を表示Recent updatesお知らせ • Jul 02Ongwe Minerals Inc. announced that it has received CAD 23.00092 million in fundingOn June 30, 2026, Ongwe Minerals Inc. has amended the terms and closed the transaction. The company will now issue 13,334,000 common shares of the Company at a price of CAD1.38 per Common Share for aggregate gross proceeds to the Company of CAD 18,400,920. This total included 2,174,000 Common Shares issued pursuant to the full exercise of the Agents' option and concurrent private placement and issued 3,333,333 Common Shares at the Issue Price for additional gross proceeds of CAD 4,600,000. The Company paid a cash commission equal to 6% of the gross proceeds of the LIFE Offering, subject to a reduced fee of 3% for sales up to CAD 3,000,000 to purchasers on a designated "President's List", and 1% for certain purchasers agreed upon between the Company and Beacon and 555,682 Broker Warrants to the Agents. Each Broker Warrant entitles the holder thereof to acquire a Common Share of the Company at a price of CAD1.38 per share, for a period of 24 months from the closing date. The Company paid Cirrus a finder's fee equal to 3% of the gross proceeds of the Private Placement. Additionally, Cirrus received up to 3% finder's fees on gross proceeds from certain purchasers in the LIFE Offering as agreed between the Company and Cirrus.お知らせ • Jun 13Ongwe Minerals Inc. announced that it expects to receive CAD 13.00086 million in fundingOngwe Minerals Inc. has entered into an agreement in connection with best efforts private placement (LIFE offering) to issue 7,247,000 common shares at a price of CAD 1.38 per common share for aggregate gross proceeds of CAD 10,000,860 and a concurrent non brokered private placement of 2,173,913 Common Shares at the issue price of CAD 1.38 per common share for aggregate gross proceeds of approximately CAD 2,999,999.94 for total aggregates of CAD 13,000,859.94 on June 11, 2026. The closing of the LIFE Offering is not conditional upon the closing of the Private Placement. The Company has agreed to pay to the Agents a cash fee of 6.0% of the gross proceeds of the LIFE Offering, and to issue to the Agents compensation options entitling the Agents to purchase a number of Common Shares equal to 6.0% of the Common Shares issued in connection with the LIFE offering at the issue price for a term of 24 months from the closing of the LIFE Offering. The LIFE Offering and Private Placement are expected to close on or about June 25, 2026. The transaction is subject to receiving all necessary regulatory approvals including the conditional approval of the TSX Venture Exchange. The Common Shares issued to Canadian subscribers pursuant to the LIFE Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. The Common Shares issued in connection with the Private Placement will be subject to a statutory hold period ending four months and a day following the closing date. The Company anticipates certain insiders of the Company may participate in the LIFE Offering. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, Prospectus Exemptions, the common shares issuable under the LIFE offering will be offered for sale to purchasers resident in each of the provinces of Canada, other than Quebec, and/or other qualifying jurisdictions, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935, Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The common shares issuable in connection with the private placement will be offered by way of private placement pursuant to applicable exemptions from prospectus requirements (other than in the listed issuer financing exemption) in each of the provinces of Canada and in such other jurisdictions outside of Canada and the United States provided it is understood that no prospectus filing or comparable obligation arises in such other jurisdiction. The Company has granted the Agents an option exercisable in whole or in part, at any time up to 48 hours prior to the Closing Date to purchase for resale up to an additional 1,087,000 Common Shares at the Issue Price for additional gross proceeds of up to CAD 1,500,060.お知らせ • Jun 10Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026.決済の安定と成長配当データの取得安定した配当: GQML.Fの 1 株当たり配当が過去に安定していたかどうかを判断するにはデータが不十分です。増加する配当: GQML.Fの配当金が増加しているかどうかを判断するにはデータが不十分です。配当利回り対市場Ongwe Minerals 配当利回り対市場GQML.F 配当利回りは市場と比べてどうか？セグメント配当利回り会社 (GQML.F)n/a市場下位25% (US)1.3%市場トップ25% (US)4.1%業界平均 (Metals and Mining)1.6%アナリスト予想 (GQML.F) (最長3年)n/a注目すべき配当: GQML.Fは最近配当金を報告していないため、配当金支払者の下位 25% に対して同社の配当利回りを評価することはできません。高配当: GQML.Fは最近配当金を報告していないため、配当金支払者の上位 25% に対して同社の配当利回りを評価することはできません。株主への利益配当収益カバレッジ: GQML.Fの 配当性向 を計算して配当金の支払いが利益で賄われているかどうかを判断するにはデータが不十分です。株主配当金キャッシュフローカバレッジ: GQML.Fが配当金を報告していないため、配当金の持続可能性を計算できません。高配当企業の発掘7D1Y7D1Y7D1YUS 市場の強力な配当支払い企業。View Management企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/07/16 12:25終値2026/06/03 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Ongwe Minerals Inc. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Jul 02Ongwe Minerals Inc. announced that it has received CAD 23.00092 million in fundingOn June 30, 2026, Ongwe Minerals Inc. has amended the terms and closed the transaction. The company will now issue 13,334,000 common shares of the Company at a price of CAD1.38 per Common Share for aggregate gross proceeds to the Company of CAD 18,400,920. This total included 2,174,000 Common Shares issued pursuant to the full exercise of the Agents' option and concurrent private placement and issued 3,333,333 Common Shares at the Issue Price for additional gross proceeds of CAD 4,600,000. The Company paid a cash commission equal to 6% of the gross proceeds of the LIFE Offering, subject to a reduced fee of 3% for sales up to CAD 3,000,000 to purchasers on a designated "President's List", and 1% for certain purchasers agreed upon between the Company and Beacon and 555,682 Broker Warrants to the Agents. Each Broker Warrant entitles the holder thereof to acquire a Common Share of the Company at a price of CAD1.38 per share, for a period of 24 months from the closing date. The Company paid Cirrus a finder's fee equal to 3% of the gross proceeds of the Private Placement. Additionally, Cirrus received up to 3% finder's fees on gross proceeds from certain purchasers in the LIFE Offering as agreed between the Company and Cirrus.
お知らせ • Jun 13Ongwe Minerals Inc. announced that it expects to receive CAD 13.00086 million in fundingOngwe Minerals Inc. has entered into an agreement in connection with best efforts private placement (LIFE offering) to issue 7,247,000 common shares at a price of CAD 1.38 per common share for aggregate gross proceeds of CAD 10,000,860 and a concurrent non brokered private placement of 2,173,913 Common Shares at the issue price of CAD 1.38 per common share for aggregate gross proceeds of approximately CAD 2,999,999.94 for total aggregates of CAD 13,000,859.94 on June 11, 2026. The closing of the LIFE Offering is not conditional upon the closing of the Private Placement. The Company has agreed to pay to the Agents a cash fee of 6.0% of the gross proceeds of the LIFE Offering, and to issue to the Agents compensation options entitling the Agents to purchase a number of Common Shares equal to 6.0% of the Common Shares issued in connection with the LIFE offering at the issue price for a term of 24 months from the closing of the LIFE Offering. The LIFE Offering and Private Placement are expected to close on or about June 25, 2026. The transaction is subject to receiving all necessary regulatory approvals including the conditional approval of the TSX Venture Exchange. The Common Shares issued to Canadian subscribers pursuant to the LIFE Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. The Common Shares issued in connection with the Private Placement will be subject to a statutory hold period ending four months and a day following the closing date. The Company anticipates certain insiders of the Company may participate in the LIFE Offering. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106, Prospectus Exemptions, the common shares issuable under the LIFE offering will be offered for sale to purchasers resident in each of the provinces of Canada, other than Quebec, and/or other qualifying jurisdictions, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106, as amended by Coordinated Blanket Order 45-935, Exemptions from Certain Conditions of the Listed Issuer Financing Exemption. The common shares issuable in connection with the private placement will be offered by way of private placement pursuant to applicable exemptions from prospectus requirements (other than in the listed issuer financing exemption) in each of the provinces of Canada and in such other jurisdictions outside of Canada and the United States provided it is understood that no prospectus filing or comparable obligation arises in such other jurisdiction. The Company has granted the Agents an option exercisable in whole or in part, at any time up to 48 hours prior to the Closing Date to purchase for resale up to an additional 1,087,000 Common Shares at the Issue Price for additional gross proceeds of up to CAD 1,500,060.
お知らせ • Jun 10Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026Ongwe Minerals Inc., Annual General Meeting, Aug 20, 2026.